Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019

SELL
$97.5 - $125.79 $2.41 Million - $3.1 Million
-24,680 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$94.4 - $126.76 $73,443 - $98,619
-778 Reduced 3.06%
24,680 $2.56 Million
Q3 2018

Nov 14, 2018

BUY
$108.41 - $127.64 $85,643 - $100,835
790 Added 3.2%
25,458 $3.35 Million
Q2 2018

Aug 08, 2018

BUY
$102.12 - $114.04 $99,056 - $110,618
970 Added 4.09%
24,668 $2.75 Million
Q1 2018

May 15, 2018

BUY
$104.31 - $124.46 $91,897 - $109,649
881 Added 3.86%
23,698 $2.58 Million
Q4 2017

Feb 07, 2018

BUY
$105.55 - $120.83 $58,052 - $66,456
550 Added 2.47%
22,817 $2.75 Million
Q3 2017

Nov 13, 2017

BUY
$106.92 - $117.79 $33,252 - $36,632
311 Added 1.42%
22,267 $2.61 Million
Q2 2017

Aug 15, 2017

BUY
N/A
21,956
21,956 $2.82 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.